Emerging and non-traditional approaches of antimicrobial drug development
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Presentation
- By: JAIN, Prateek (Biopharma Insights, India)
Ten million per year globally, is the estimated number of deaths that will be attributable to antimicrobial resistance by the year 2050. By cause of pathogens acquiring resistance to almost all available antibiotic classes, unfortunately, even the last resort antibiotics have become ineffective in certain reported cases. If we do not act now, the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.